Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
63 items
National Eye Institute logo.

Clinical Trial of Docosahexaenoic Acid in Patients with Retinitis Pigmentosa Receiving Vitamin A Treatment

Docosahexaenoic acid (DHA) supplementation at a dose of 1200 milligrams per day for four years did not, on average, slow the course of retinitis pigmentosa (RP) in adult RP patients already taking vitamin A supplements..
National Eye Institute logo.

Stem Cell Procedure Protects Mice from Degenerative Retinal Diseases; May Be Promising for People with Similar Retinal Diseases

An experimental 'rescue' of retinas by treating eyes with certain stem cells has been shown to preserve visual function in mice that were genetically predisposed to degenerative diseases of the retina.
National Eye Institute logo.

Treatment for Retinitis Pigmentosa Reported

Most adults with blinding retinitis pigmentosa (RP) should take a daily, 15,000 IU vitamin A supplement, based on results from a large, randomized clinical trial published today in the Archives of Ophthalmology.

Want more news from NEI?

Connect with us through social media to stay up to date on vision research, eye health, and other topics!

NEI Press Office

We can connect media professionals with the latest vision research info. Get in touch!


Phone: 301-496-5248